{
  "id": 1146274,
  "title": "Chemours co president Michael Foley buys $29,999 in stock",
  "url": "https://urgent.news/2026/08/15/chemours-co-president-michael-foley-buys-29-999-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-15T23:19:29.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/chemours-co-president-michael-foley-buys-29999-in-stock-93CH-4861875"
  },
  "original_language": "en",
  "account": "Chemours Company President Michael Foley made a notable stock purchase on August 7, 2026, acquiring 1,934.2313 shares at a price of $15.51 to $15.54 per share, amounting to $29,999. This investment brings Mr. Foley's total ownership of Chemours common stock to 80,777.2308 shares, encompassing directly held shares, restricted stock units, and dividend equivalent units. The transaction took place at a time when Chemours shares were trading at $15.85, reflecting a 22% decrease over the past six months, despite a 36% increase year-to-date. Despite the overall stock market performance, the company's shares are considered slightly overvalued based on InvestingPro analysis, placing Chemours on the Most Overvalued list. Chemours offers a dividend yield of 2.21% and holds a market capitalization of $2.3 billion. Investors can find further analysis through InvestingPro Tips and a Pro Research Report. In light of recent news, Chemours reported second-quarter 2026 earnings that fell short of expectations, reporting $0.42 per share on $1.59 billion in revenue, failing to meet analysts' estimates of $0.50 per share and $1.66 billion in sales. UBS recently downgraded Chemours from Buy to Neutral, adjusting its price target to $18.00, citing concerns about potential market share loss and destocking issues anticipated within 2026, particularly within Chemours’ refrigerant business.",
  "summary": null,
  "key_points": [
    "Michael Foley purchased 1,934.2313 shares of Chemours stock on August 7, 2026.",
    "The stock purchase cost $29,999 at $15.51 to $15.54 per share.",
    "Foley's total Chemours stock ownership increased to 80,777.2308 shares."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Chemours president Martinko buys $30,008 in company stock",
        "url": "https://urgent.news/2026/08/15/chemours-president-martinko-buys-30-008-in-company-stock",
        "published": "2026-08-15T23:15:51.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}